Our hypothesis was that pTEN loss, a common feature in castrate-resistant prostate cancer patients and seen in AR-positive LNCaP and AR-negative PC-3 cells, reduces the influence of resveratrol on maximum synergy in DU145 cells. The gene discussed is AR; the disease is prostate carcinoma.